Citation for published version (APA): Geel, T. M. (2010). Pompe disease: towards gene correction using targeted nucleases Groningen: s.n.

Transcription

1 University of Groningen Pompe disease Geel, Tessa Marieke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2010 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Geel, T. M. (2010). Pompe disease: towards gene correction using targeted nucleases Groningen: s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date:

2 Chapter 11 List of Publications 141

3 Publication list Publication list Articles Selective targeting of adenovirus to alpha(v)beta(3) integrins, VEGFR2 and Tie2 endothelial receptors by angioadenobodies H.J. Haisma, G.K. Kamps, A. Bouma, T.M. Geel, M.G. Rots, A. Kariat, A.R. Bellu, Int J Pharm (2010) Endonucleases to induce apoptosis in TRAIL-insensitive ovarian carcinoma cells Tessa M. Geel, Gregor Meiss, Bernardina T. van der Gun, Bart Jan Kroesen, Lou F. de Leij, Mindaugas Zaremba, Arūnas Šilanskas, Michael Kokkinidis, Alfred Pingoud, Marcel H. Ruiters, Marianne G. Rots, Pamela M. McLaughlin, Experimental cell Research (2009) Pompe disease: Current state of treatment modalities and animal models Tessa M. Geel, Petra Voorn, Lou F.M.H. de Leij, Marcel H.J. Ruiters, Klary E. Niezen-Koning, Molecular Genetics and Metabolism 92: (2007) Published abstracts The generation of animal models to design novel gene correction approaches for Pompe disease, T.M. Geel, K.E. Niezen-Koning, M.H.J. Ruiters, P. Voorn, P.M.J. McLaughlin, A. Pingoud, V. Siksnys, M. Rots, Human Gene Therapy 19: (2008) Nonmodified sirna leads to downregulation of alpha-glucosidase: Towards a mouse model for M Pompe, T.M. Geel, P.Voorn, M.H.J. Ruiters, K.E. Niezen-Koning, Clinical Therapeutics, 30: s28-28, Suppl. A (2008) Nonmodified sirna leads to downregulation of alpha-glucosidase: Towards a mouse model for M Pompe, T.M. Geel, P. Voorn, M.H.J. Ruiters, K.E. Niezen-Koning, Journal of Inherited Metabolic Disease, 30: , Suppl. 1 (2007) Angio-adenobodies are able to target adenovirus to tumor endothelium in vivo, A.R. Bellu, G.K. Kamps, T.M. Geel, A. Kariat, A. Bouma, H.J. Haisma, Human Gene Therapy 18: (2007) Presentations Delivery of TFO-conjugated nucleases using SAINT - an update International presentation, project meeting, Hannover, Germany (2009) Delivery of TFO-conjugated nucleases using SAINT International presentation, project meeting, Paris, France (2008) Apoptosis induction in ovarian carcinoma cell lines via delivery of restriction enzymes using SAINT International presentation, project meeting, Frankfurt, Germany (2007) Meganucleases as tool for gene replacement therapy in Pompe Disease Group Prof. Dr. A. Pingoud, Institute of Biochemistry, Faculty of Biology and Chemistry, Justus-Liebig-University- Gieβen, Germany (2007) Conjugation of a TFO to the endonuclease PvuII International presentation, project meeting, Vilnius, Lithuania (2007) Nonmodified sirna leads to downregulation of alpha-glucosidase: towards a mouse model for Pompe disease Congress European Study Group on Lysosomal Diseases, Perugia, Italy (2007) Nonmodified sirna leads to downregulation of alpha-glucosidase: towards a mouse model for Pompe disease Congress Steps forward in Pompe disease, Nice, France (2007) 142

4 Publication list Meganucleases as tool for gene replacement therapy in Pompe Disease International presentation, project meeting, Crete, Greece (2006) Funding and awards Award best abstract Nonmodified sirna leads to downregulation of alpha-glucosidase: towards a mouse model for Pompe disease, Steps forward in Pompe disease, Nice, France (2007) Funding JC de Cock-stichting The development of an animal model for lysosomal storage disease type II (Pompe Disease) using knockdown technology (2006)

5 144